Clinical trial
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
NCT00099749 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00099749 |
|---|---|
| Title | Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant |
| Official title | Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | FTY 720 |
| Enrollment | 255 |
| Start date | Nov 1, 2003 |
| Primary completion | Apr 1, 2006 |
| First posted | Dec 20, 2004 |
| Last update posted | Feb 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: